ArticleOncoTargets and therapy2021

Promising Response to Lenalidomide-Combination Therapy in a Discordant Lymphoma Consisting of EBV-Positive Diffuse Large B-Cell Lymphoma and Angioimmunoblastic T-Cell Lymphoma: A Case Report.

Pan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.